
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pathogenetics of the RASopathies
William E. Tidyman, Katherine A. Rauen
Human Molecular Genetics (2016) Vol. 25, Iss. R2, pp. R123-R132
Open Access | Times Cited: 112
William E. Tidyman, Katherine A. Rauen
Human Molecular Genetics (2016) Vol. 25, Iss. R2, pp. R123-R132
Open Access | Times Cited: 112
Showing 1-25 of 112 citing articles:
RAS Proteins and Their Regulators in Human Disease
Dhirendra K. Simanshu, Dwight V. Nissley, Frank McCormick
Cell (2017) Vol. 170, Iss. 1, pp. 17-33
Open Access | Times Cited: 1581
Dhirendra K. Simanshu, Dwight V. Nissley, Frank McCormick
Cell (2017) Vol. 170, Iss. 1, pp. 17-33
Open Access | Times Cited: 1581
KRAS Alleles: The Devil Is in the Detail
Kevin M. Haigis
Trends in cancer (2017) Vol. 3, Iss. 10, pp. 686-697
Open Access | Times Cited: 321
Kevin M. Haigis
Trends in cancer (2017) Vol. 3, Iss. 10, pp. 686-697
Open Access | Times Cited: 321
The NF1 somatic mutational landscape in sporadic human cancers
Charlotte Philpott, Hannah Tovell, Ian M. Frayling, et al.
Human Genomics (2017) Vol. 11, Iss. 1
Open Access | Times Cited: 261
Charlotte Philpott, Hannah Tovell, Ian M. Frayling, et al.
Human Genomics (2017) Vol. 11, Iss. 1
Open Access | Times Cited: 261
The RASopathy Family: Consequences of Germline Activation of the RAS/MAPK Pathway
Mylène Tajan, Romain Paccoud, Sophie Branka, et al.
Endocrine Reviews (2018) Vol. 39, Iss. 5, pp. 676-700
Open Access | Times Cited: 196
Mylène Tajan, Romain Paccoud, Sophie Branka, et al.
Endocrine Reviews (2018) Vol. 39, Iss. 5, pp. 676-700
Open Access | Times Cited: 196
Targeted Genomic Profiling of Acral Melanoma
Iwei Yeh, Eric Jorgenson, Ling Shen, et al.
JNCI Journal of the National Cancer Institute (2019) Vol. 111, Iss. 10, pp. 1068-1077
Open Access | Times Cited: 154
Iwei Yeh, Eric Jorgenson, Ling Shen, et al.
JNCI Journal of the National Cancer Institute (2019) Vol. 111, Iss. 10, pp. 1068-1077
Open Access | Times Cited: 154
The RASopathies: from pathogenetics to therapeutics
Katie E. Hebron, Edjay R. Hernandez, Marielle E. Yohe
Disease Models & Mechanisms (2022) Vol. 15, Iss. 2
Open Access | Times Cited: 117
Katie E. Hebron, Edjay R. Hernandez, Marielle E. Yohe
Disease Models & Mechanisms (2022) Vol. 15, Iss. 2
Open Access | Times Cited: 117
The role of CRAF in cancer progression: from molecular mechanisms to precision therapies
Melody Riaud, Jennifer Maxwell, Isabel Soria‐Bretones, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 2, pp. 105-122
Closed Access | Times Cited: 22
Melody Riaud, Jennifer Maxwell, Isabel Soria‐Bretones, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 2, pp. 105-122
Closed Access | Times Cited: 22
ClinGen’s RASopathy Expert Panel consensus methods for variant interpretation
Bruce D. Gelb, Hélène Cavé, Mitchell W. Dillon, et al.
Genetics in Medicine (2018) Vol. 20, Iss. 11, pp. 1334-1345
Open Access | Times Cited: 147
Bruce D. Gelb, Hélène Cavé, Mitchell W. Dillon, et al.
Genetics in Medicine (2018) Vol. 20, Iss. 11, pp. 1334-1345
Open Access | Times Cited: 147
Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals
Praveen Surendran, Elena V. Feofanova, Najim Lahrouchi, et al.
Nature Genetics (2020) Vol. 52, Iss. 12, pp. 1314-1332
Open Access | Times Cited: 137
Praveen Surendran, Elena V. Feofanova, Najim Lahrouchi, et al.
Nature Genetics (2020) Vol. 52, Iss. 12, pp. 1314-1332
Open Access | Times Cited: 137
Costello syndrome: Clinical phenotype, genotype, and management guidelines
Karen W. Gripp, Lindsey A. Morse, Marni E. Axelrad, et al.
American Journal of Medical Genetics Part A (2019) Vol. 179, Iss. 9, pp. 1725-1744
Open Access | Times Cited: 111
Karen W. Gripp, Lindsey A. Morse, Marni E. Axelrad, et al.
American Journal of Medical Genetics Part A (2019) Vol. 179, Iss. 9, pp. 1725-1744
Open Access | Times Cited: 111
RIT1 oncoproteins escape LZTR1-mediated proteolysis
Pau Castel, Alice Cheng, Antonio Cuevas-Navarro, et al.
Science (2019) Vol. 363, Iss. 6432, pp. 1226-1230
Open Access | Times Cited: 96
Pau Castel, Alice Cheng, Antonio Cuevas-Navarro, et al.
Science (2019) Vol. 363, Iss. 6432, pp. 1226-1230
Open Access | Times Cited: 96
Pharmacological Inhibition of ERK Signaling Rescues Pathophysiology and Behavioral Phenotype Associated with 16p11.2 Chromosomal Deletion in Mice
Joanna Pucilowska, Joseph Vithayathil, Marco Pagani, et al.
Journal of Neuroscience (2018) Vol. 38, Iss. 30, pp. 6640-6652
Open Access | Times Cited: 84
Joanna Pucilowska, Joseph Vithayathil, Marco Pagani, et al.
Journal of Neuroscience (2018) Vol. 38, Iss. 30, pp. 6640-6652
Open Access | Times Cited: 84
The Ras Superfamily of Small GTPases in Non-neoplastic Cerebral Diseases
Liang Qu, Chao Pan, Shiming He, et al.
Frontiers in Molecular Neuroscience (2019) Vol. 12
Open Access | Times Cited: 76
Liang Qu, Chao Pan, Shiming He, et al.
Frontiers in Molecular Neuroscience (2019) Vol. 12
Open Access | Times Cited: 76
SOS GEFs in health and disease
Fernando C. Baltanás, Natasha Zarich, José M. Rojas, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1874, Iss. 2, pp. 188445-188445
Open Access | Times Cited: 71
Fernando C. Baltanás, Natasha Zarich, José M. Rojas, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1874, Iss. 2, pp. 188445-188445
Open Access | Times Cited: 71
Defining RASopathy
Katherine A. Rauen
Disease Models & Mechanisms (2022) Vol. 15, Iss. 2
Open Access | Times Cited: 61
Katherine A. Rauen
Disease Models & Mechanisms (2022) Vol. 15, Iss. 2
Open Access | Times Cited: 61
How can same-gene mutations promote both cancer and developmental disorders?
Ruth Nussinov, Chung‐Jung Tsai, Hyunbum Jang
Science Advances (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 48
Ruth Nussinov, Chung‐Jung Tsai, Hyunbum Jang
Science Advances (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 48
The molecular genetics of RASopathies : An update on novel disease genes and new disorders
Marco Tartaglia, Yoko Aoki, Bruce D. Gelb
American Journal of Medical Genetics Part C Seminars in Medical Genetics (2022) Vol. 190, Iss. 4, pp. 425-439
Open Access | Times Cited: 43
Marco Tartaglia, Yoko Aoki, Bruce D. Gelb
American Journal of Medical Genetics Part C Seminars in Medical Genetics (2022) Vol. 190, Iss. 4, pp. 425-439
Open Access | Times Cited: 43
Dominant Noonan syndrome-causing LZTR1 mutations specifically affect the Kelch domain substrate-recognition surface and enhance RAS-MAPK signaling
Marialetizia Motta, Miray Fidan, Emanuele Bellacchio, et al.
Human Molecular Genetics (2018) Vol. 28, Iss. 6, pp. 1007-1022
Open Access | Times Cited: 82
Marialetizia Motta, Miray Fidan, Emanuele Bellacchio, et al.
Human Molecular Genetics (2018) Vol. 28, Iss. 6, pp. 1007-1022
Open Access | Times Cited: 82
RAS variant signalling
Stephanie Mo, Judy M. Coulson, Ian A. Prior
Biochemical Society Transactions (2018) Vol. 46, Iss. 5, pp. 1325-1332
Open Access | Times Cited: 80
Stephanie Mo, Judy M. Coulson, Ian A. Prior
Biochemical Society Transactions (2018) Vol. 46, Iss. 5, pp. 1325-1332
Open Access | Times Cited: 80
Turning the tide in myelodysplastic/myeloproliferative neoplasms
Michael W. Deininger, Jeffrey W. Tyner, Éric Solary
Nature reviews. Cancer (2017) Vol. 17, Iss. 7, pp. 425-440
Closed Access | Times Cited: 76
Michael W. Deininger, Jeffrey W. Tyner, Éric Solary
Nature reviews. Cancer (2017) Vol. 17, Iss. 7, pp. 425-440
Closed Access | Times Cited: 76
Emerging therapeutic targets for neurofibromatosis type 1
James A. Walker, Meena Upadhyaya
Expert Opinion on Therapeutic Targets (2018) Vol. 22, Iss. 5, pp. 419-437
Open Access | Times Cited: 72
James A. Walker, Meena Upadhyaya
Expert Opinion on Therapeutic Targets (2018) Vol. 22, Iss. 5, pp. 419-437
Open Access | Times Cited: 72
Intronic CRISPR Repair in a Preclinical Model of Noonan Syndrome–Associated Cardiomyopathy
Ulrich Hanses, Mandy Kleinsorge, Lennart Roos, et al.
Circulation (2020) Vol. 142, Iss. 11, pp. 1059-1076
Open Access | Times Cited: 66
Ulrich Hanses, Mandy Kleinsorge, Lennart Roos, et al.
Circulation (2020) Vol. 142, Iss. 11, pp. 1059-1076
Open Access | Times Cited: 66
Germline and sporadic cancers driven by the RAS pathway: parallels and contrasts
Victoria Dunnett-Kane, Emma Burkitt‐Wright, Fiona Blackhall, et al.
Annals of Oncology (2020) Vol. 31, Iss. 7, pp. 873-883
Open Access | Times Cited: 53
Victoria Dunnett-Kane, Emma Burkitt‐Wright, Fiona Blackhall, et al.
Annals of Oncology (2020) Vol. 31, Iss. 7, pp. 873-883
Open Access | Times Cited: 53
DNA damage in testicular germ cells and spermatozoa. When and how is it induced? How should we measure it? What does it mean?
R. John Aitken, Sheena E.M. Lewis
Andrology (2023) Vol. 11, Iss. 8, pp. 1545-1557
Open Access | Times Cited: 22
R. John Aitken, Sheena E.M. Lewis
Andrology (2023) Vol. 11, Iss. 8, pp. 1545-1557
Open Access | Times Cited: 22
Activating mutations in the MAP‐kinase pathway define non‐ossifying fibroma of bone
Daniel Baumhoer, Michal Kováč, Jan Sperveslage, et al.
The Journal of Pathology (2018) Vol. 248, Iss. 1, pp. 116-122
Open Access | Times Cited: 59
Daniel Baumhoer, Michal Kováč, Jan Sperveslage, et al.
The Journal of Pathology (2018) Vol. 248, Iss. 1, pp. 116-122
Open Access | Times Cited: 59